CUMYL-THPINACA
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C23H27N3O2 |
| Molar mass | 377.488 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
CUMYL-THPINACA (also known as SGT-42) is an indazole-3-carboxamide based synthetic cannabinoid.[1][2] CUMYL-THPINACA acts as a potent agonist for the cannabinoid receptors, with approximately 6x selectivity for CB1, having an EC50 of 0.1nM for human CB1 receptors and 0.59nM for human CB2 receptors.[3]
Legal status[edit]
Sweden's public health agency suggested to classify CUMYL-THPINACA as hazardous substance on November 10, 2014.[4]
As of October 2015 CUMYL-THPINACA is a controlled substance in China.[5]
See also[edit]
- 5F-CUMYL-PINACA
- 5F-SDB-006
- ADAMANTYL-THPINACA
- CUMYL-4CN-BINACA
- CUMYL-CBMINACA
- CUMYL-PICA
- CUMYL-PINACA
- SDB-006
- NNE1
References[edit]
- ^ "CUMYL-THPINACA". Cayman Chemical. Retrieved 11 July 2015.
- ^ Monti MC, Scheurer E, Mercer-Chalmers-Bender K (July 2021). "Phase I In Vitro Metabolic Profiling of the Synthetic Cannabinoid Receptor Agonists CUMYL-THPINACA and ADAMANTYL-THPINACA". Metabolites. 11 (8): 470. doi:10.3390/metabo11080470. PMC 8398790. PMID 34436411.
- ^ WO 2014167530, Bowden MJ, Williamson JP, "Cannabinoid compounds", published 2014-10-16
- ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 11 July 2015.
- ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.
 | This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |